07/03/2024
4:27 PM | Arrowhead Pharmaceuticals (Issuer)
Oliver Tracie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:09 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
5:04 PM | Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
1:39 PM | Arrowhead Pharmaceuticals (Subject)
Vakiener Victoria (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
1:03 PM | Arrowhead Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
04/03/2024
5:05 PM | Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:30 PM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/20/2024
6:06 PM | Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:38 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
6:00 PM | Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/08/2024
4:54 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:30 PM | Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:25 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:57 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/26/2024
4:28 PM | Arrowhead Pharmaceuticals (Filer)
| Form DEFA14A | |
01/24/2024
11:57 AM | Arrowhead Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/23/2024
3:14 PM | Arrowhead Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/17/2024
5:32 PM | Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:22 PM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144/A | |
01/16/2024
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:48 PM | Arrowhead Pharmaceuticals (Subject)
Vakiener Victoria (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024
3:38 PM | Arrowhead Pharmaceuticals (Subject)
Arrowhead Pharmaceuticals (Subject)
Waddill William D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024
3:22 PM | Arrowhead Pharmaceuticals (Subject)
Ferrari Mauro (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
4:16 PM | Arrowhead Pharmaceuticals (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:16 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:17 PM | Arrowhead Pharmaceuticals (Issuer)
Oliver Tracie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
6:58 PM | Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
7:02 PM | Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
4:33 PM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
4:14 PM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
3:39 PM | Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
3:21 PM | Arrowhead Pharmaceuticals (Subject)
San Martin Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
3:08 PM | Arrowhead Pharmaceuticals (Subject)
Oliver Tracie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
4:25 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:27 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
12:49 PM | Arrowhead Pharmaceuticals (Subject)
O'Brien Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
12:06 PM | Arrowhead Pharmaceuticals (Subject)
O'Brien Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
12:25 PM | Arrowhead Pharmaceuticals (Subject)
O'Brien Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
01/04/2024
11:24 AM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:44 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
4:04 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
3:34 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023
2:51 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
2:52 PM | Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
2:54 PM | Arrowhead Pharmaceuticals (Issuer)
OLUKOTUN ADEOYE Y (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
2:55 PM | Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
2:41 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
4:16 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
3:10 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
1:31 PM | Arrowhead Pharmaceuticals (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/27/2023
5:23 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
4:51 PM | Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/28/2023
1:50 PM | Arrowhead Pharmaceuticals (Subject)
Vakiener Victoria (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023
5:10 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:20 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
